Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients

and Genetic Barrier towards Resistance in a Clinical Cohort of HIV-1 Treated Patients K Deforche1, A Cozzi-Lepri2, K Theys1, B Clotet3, R Camacho4, J Kjaer5, K Van Laethem1, AN Phillips2, Y Moreau1, JD Lundgren5 and A-M Vandamme1 for the EuroSIDA study Group 1Katholieke Universiteit Leuven, Leuven, Belgium; 2Royal Free and University College Medical School, London, UK; 3University Hospital Germans Trias i Pujol, Barcelona, Spain; 4Centro Hospitalar de Lisboa, Lisbon, Portugal, 5Copenhagen HIV Programme, Copenhagen, Denmark.